BIOMAT Database Logo BIOMAT Database Logo

BCG immunotherapy in chronic myelocytic leukaemia. 1976

E Kardaszewicz, and L Siejeńska

UI MeSH Term Description Entries
D007115 Immunization Schedule Schedule giving optimum times usually for primary and/or secondary immunization. Immunization Schedules,Schedule, Immunization,Schedules, Immunization
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002066 Busulfan An alkylating agent having a selective immunosuppressive effect on BONE MARROW. It has been used in the palliative treatment of chronic myeloid leukemia (MYELOID LEUKEMIA, CHRONIC), but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen. Busulphan,Busulfan Wellcome,Busulfex,Glyzophrol,Myelosan,Mylecytan,Myleran,Myléran,n-Butane-1,3-di(methylsulfonate),Wellcome, Busulfan
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

E Kardaszewicz, and L Siejeńska
Splenectomy in chronic myelocytic leukaemia.
March 1975, Acta medica Scandinavica,
E Kardaszewicz, and L Siejeńska
Chronic myelocytic leukaemia in African children.
January 1971, Transactions of the Royal Society of Tropical Medicine and Hygiene,
E Kardaszewicz, and L Siejeńska
Immunotherapy of chronic myelocytic leukemia.
December 1973, National Cancer Institute monograph,
E Kardaszewicz, and L Siejeńska
Chronic myelocytic leukaemia presenting in blastic transformation. Two cases primarily diagnosed as acute myelocytic leukaemia.
April 1977, Scandinavian journal of haematology,
E Kardaszewicz, and L Siejeńska
Immunotherapy in well-controlled chronic myelocytic leukemia.
May 1973, New York state journal of medicine,
E Kardaszewicz, and L Siejeńska
G-G translocation and chronic myelocytic leukaemia.
September 1974, Blut,
E Kardaszewicz, and L Siejeńska
The possibility of radical chemotherapy in chronic myelocytic leukaemia.
January 1969, Haematologica Latina,
E Kardaszewicz, and L Siejeńska
The immunotherapy of acute myelogenous leukaemia using intravenous BCG.
September 1977, British journal of haematology,
E Kardaszewicz, and L Siejeńska
The immunotherapy of acute myelogenous leukaemia using intravenous BCG.
February 1977, British journal of haematology,
E Kardaszewicz, and L Siejeńska
Chronic myelocytic leukaemia in a patient with sickle cell anaemia.
November 1986, The Journal of the Association of Physicians of India,
Copied contents to your clipboard!